Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
SBC to Revenue
149.77%
Quarterly · Period ending:
LCTX SBC to Revenue
Latest reported149.77%period ending
Latest reported149.77%period ending
LCTX Quarterly SBC/Revenue (0.00% → 149.77%)
Latest values, visible window
High-resolution chart · PNG
LCTX sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 149.7661% | |
| 67.942% | |
| 16.6162% | |
| 32.5727% | |
| 44.774% | |
| 81.0253% | |
| 45.8508% | |
| 35.1945% | |
| 90.1278% | |
| 80.5402% | |
| 50.7663% | |
| 101.8459% | |
| 39.6899% | |
| 43.2104% | |
| 50.0783% | |
| 32.9219% | |
| 27.125% | |
| 21.119% | |
| 95.625% | |
| 51.9074% | |
| 208.39% | |
| 183.959% | |
| 297.5904% | |
| 146.4912% | |
| 612.1212% | |
| 377.1084% | |
| 74.399% | |
| 349.7696% | |
| 304.8% | |
| 804.4693% | |
| 1,172.5146% | |
| 496.2121% | |
| 182.0132% | |
| 262.4% | |
| 180.8436% | |
| 210.1512% | |
| 237.2703% | |
| 270.7124% | |
| 217.4142% | |
| 182.0513% | |
| 438.7352% | |
| 575.5973% | |
| 695.6757% | |
| 415.3571% | |
| 312.1666% | |
| 338.4647% | |
| 255.4338% | |
| 203.9715% | |
| 302.2691% | |
| 163.2573% | |
| 66.8465% | |
| 184.8811% | |
| 149.3598% | |
| 108.9151% | |
| 57.0741% | |
| 37.0947% | |
| 28.8727% | |
| 50.0135% | |
| 23.8563% | |
| 23.4733% | |
| 35.8072% | |
| 35.1115% | |
| 14.7488% | |
| 17.8226% | |
| 21.3595% | |
| 18.0969% | |
| 48.5902% | |
| 12.4013% | |
| 8.6757% | |
| 10.6281% | |
| 47.153% | |
| 0% | |
| 0% | |
| 10.3313% | |
| 42.1337% | |
| 2.4758% | |
| 8.0516% | |
| 20.6908% | |
| 23.7418% | |
| 0% | |
| 0% | |
| 6.2256% | |
| 65.7659% | |
| 0% | |
| 0% | |
| 7.8762% | |
| 0% | |
| 0% | |
| 0% | |
| 36.9365% | |
| 0% | |
| 0% | |
| 0% | |
| 40.1047% | |
| 104.7999% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |